Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Claudia Tavera-Alonso"'
Autor:
Kietseé A. Díaz-Domínguez, Andrés Cruz-Melendez, Luis M. Amezcua-Castillo, Jazmin A. Guerra-López, Claudia Tavera-Alonso, Hector González-Pacheco, Luis M. Amezcua-Guerra
Publikováno v:
Archivos de Cardiología de México, Vol 93, Iss 96 (2023)
Antecedentes y Objetivo: Evaluar si una infección reciente por SARS-CoV-2 podría ser en sí misma un factor de riesgo o pronóstico para el infarto de miocardio con elevación del segmento ST (IAMCEST). Método: Realizamos un estudio observacional
Externí odkaz:
https://doaj.org/article/74f86be291a84d1ca5eac2e569110232
Autor:
Luis M Amezcua-Guerra, Leonardo del Valle, Héctor González-Pacheco, Rashidi Springall, Ricardo Márquez-Velasco, Felipe Massó, Malinalli Brianza-Padilla, Daniel Manzur-Sandoval, Julieta González-Flores, Carlos García-Ávila, Yaneli Juárez-Vicuña, Fausto Sánchez-Muñoz, Martha A Ballinas-Verdugo, Edna Basilio-Gálvez, Araceli Paez-Arenas, Mauricio Castillo-Salazar, Sergio Cásares-Alvarado, Adrián Hernández-Diazcouder, José L Sánchez-Gloria, Claudia Tavera-Alonso, Rodrigo Gopar-Nieto, Julio Sandoval
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 16 (2022)
Background: Information about angiotensin II (Ang II), angiotensin-converting enzyme 2 (ACE2), and Ang-(1–7) levels in patients with COVID-19 is scarce. Objective: To characterize the Ang II–ACE2–Ang-(1–7) axis in patients with SARS-CoV-2 inf
Externí odkaz:
https://doaj.org/article/78c43c6947294aaaae6435b9fae4f8ef
Autor:
Brianda Amezcua-Guerra, Luis M. Amezcua-Castillo, Jazmín A. Guerra-López, Kietseé A. Díaz-Domínguez, José L. Sánchez-Gloria, Andrés Cruz-Melendez, Adrián Hernández-Díazcouder, Yaneli Juárez-Vicuña, Fausto Sánchez-Muñoz, Fengyang Huang, Claudia Tavera-Alonso, Malinalli Brianza-Padilla, Elvira Varela-López, Daniel Sierra-Lara, Alexandra Arias-Mendoza, Gabriela Fonseca-Camarillo, Ricardo Márquez-Velasco, Héctor González-Pacheco, Rashidi Springall, Luis M. Amezcua-Guerra
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2422 (2023)
Prompt diagnosis of ST-segment elevation myocardial infarction (STEMI) is essential for initiating timely treatment. MicroRNAs have recently emerged as biomarkers in cardiovascular diseases. This study aimed to evaluate the discriminatory capacity of
Externí odkaz:
https://doaj.org/article/67c68269b620464b926d0be487f6ceff
Autor:
Luis M. Amezcua-Guerra, Fernanda Espinosa-Bautista, Karen Hopf-Estandía, Melisa Valdivieso-Ruiz, Dania Coronel, Sandra Robledo, Varna Ramos-Rosillo, María del Rocío Martínez-Alvarado, Mariana Patlán, Araceli Páez, Luis H. Silveira, Claudia Tavera-Alonso, Felipe Massó, Carina Soto-Fajardo, Carlos Pineda
Publikováno v:
Clinical Rheumatology.
Autor:
Kietseé A, Díaz-Domínguez, Andrés, Cruz-Melendez, Luis M, Amezcua-Castillo, Jazmin A, Guerra-López, Claudia, Tavera-Alonso, Héctor, González-Pacheco, Luis M, Amezcua-Guerra
Publikováno v:
Archivos de Cardiología de México.
The aim of the study was to assess whether a recent SARS-CoV-2 infection could by itself be a risk or prognostic factor for ST-segment elevation myocardial infarction (STEMI).An observational study in unvaccinated patients with STEMI confirmed by car
Autor:
null Luis M Amezcua-Guerra, null Leonardo del Valle, null Héctor González-Pacheco, null Rashidi Springall, null Ricardo Márquez-Velasco, null Felipe Massó, null Malinalli Brianza-Padilla, null Daniel Manzur-Sandoval, null Julieta González-Flores, null Carlos García-Ávila, null Yaneli Juárez-Vicuña, null Fausto Sánchez-Muñoz, null Martha A Ballinas-Verdugo, null Edna Basilio-Gálvez, null Araceli Paez-Arenas, null Mauricio Castillo-Salazar, null Sergio Cásares-Alvarado, null Adrián Hernández-Diazcouder, null José L Sánchez-Gloria, null Claudia Tavera-Alonso, null Rodrigo Gopar-Nieto, null Julio Sandoval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bec11c487615ec139fb7757092349a91
https://doi.org/10.1177/17534666221122544/v3/response1
https://doi.org/10.1177/17534666221122544/v3/response1
Autor:
Diana Santiago, Juan Guzmán, Julio Sandoval, Zaira Torres, Héctor González-Pacheco, Claudia Tavera-Alonso, Karen Audelo, Luis M. Amezcua-Guerra, Julieta González-Flores, Carlos García-Ávila, Francisco M. Baranda-Tovar
Publikováno v:
Inflammation Research
Objective To investigate whether a simplified inflammation-based risk scoring system comprising three readily available biomarkers (albumin, C-reactive protein, and leukocytes) may predict major adverse outcomes in patients with COVID-19. Methods Upo
Autor:
Rashidi Springall, Julieta González-Flores, Carlos García-Ávila, Yaneli Juárez-Vicuña, Adrián Hernández-Diazcouder, Ricardo Márquez-Velasco, Sergio Cásares-Alvarado, Fausto Sánchez-Muñoz, Edna Basilio-Gálvez, Mauricio Castillo-Salazar, Martha A. Ballinas-Verdugo, Malinalli Brianza-Padilla, José L. Sánchez-Gloria, Claudia Tavera-Alonso, Julio Sandoval, Héctor González-Pacheco, Luis M. Amezcua-Guerra
Publikováno v:
Archivum immunologiae et therapiae experimentalis. 70(1)
To evaluate soluble CD147 levels in COVID-19 and identify whether these are associated with hyperinflammation and disease severity. One-hundred and nine COVID-19 patients and 72 healthy blood donors were studied. Levels of CD147, matrix metalloprotea
Autor:
Yaneli Juárez-Vicuña, Edna Basilio-Gálvez, Martha A Ballinas-Verdugo, Claudia Tavera-Alonso, Francisco M. Baranda-Tovar, Mauricio Castillo-Salazar, Rashidi Springall, Héctor González-Pacheco, Carlos García-Ávila, Ricardo Márquez-Velasco, Fausto Sánchez-Muñoz, Julieta González-Flores, Malinalli Brianza-Padilla, Gustavo Rojas-Velasco, Julio Sandoval, José L. Sánchez-Gloria, Sergio Cásarez-Alvarado, Adrián Hernández-Díazcouder, Luis M. Amezcua-Guerra
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 3657, p 3657 (2021)
Journal of Clinical Medicine
Volume 10
Issue 16
Journal of Clinical Medicine
Volume 10
Issue 16
Background: Several easy-to-use risk scoring systems have been built to identify patients at risk of developing complications associated with COVID-19. However, information about the ability of each score to early predict major adverse outcomes durin
Autor:
Yaneli Juárez-Vicuña, Claudia Tavera-Alonso, Armando Vazquez-Rangel, Malinalli Brianza-Padilla, Luis M. Amezcua-Guerra, Marisol Hernández-Salas, Fausto Sánchez-Muñoz, Gustavo Rojas-Velasco, Ricardo Márquez-Velasco, Francisco M. Baranda-Tovar, Rashidi Springall, Héctor González-Pacheco
Publikováno v:
Annals of the Rheumatic Diseases
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its associated coagulopathy are particularly worrisome in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), as these diseases carry an